Navigation Links
Vitamin deficiency after weight loss surgery can cause vision loss in newborns
Date:7/16/2010

St. Louis, MO, July 16, 2010 Biliopancreatic diversion surgery for morbid obesity is known to cause multiple vitamin deficiencies that may worsen during pregnancy. In the June issue of the Journal of AAPOS, the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus, a group of Australian clinicians report a child who was born blind as a result of Vitamin A deficiency caused by his mother's obesity surgery.

Clinical investigators from Australia documented the case of a woman who had undergone biliopancreatic diversion surgery for obesity 7 years before the birth of her child. At 9 weeks gestation, the mother was diagnosed with severe deficiencies of Vitamins A, D and K, as well as iron-deficiency anemia, which had been undetected prior to this point. Despite treatment, her serum vitamin A level remained critically low throughout the pregnancy. Her infant son had significant malformations of both eyes, and his vision remains poor despite treatment. For the fetus, the first 8 weeks of gestation are the most critical time for organs to develop, including the formation of the visual system,

Lead investigator Glen Gole, MD, FRANZCO, Department of Ophthalmology, Royal Children's Hospital and Discipline of Paediatrics and Child Health, University of Queensland, Brisbane, states, "The mother's description of night blindness, recurrent low vitamin A levels during the pregnancy, and demonstrated vitamin A deficiency in the neonate support vitamin A deficiency as the cause. This case illustrates that vitamin A is very important for normal eye development in the fetus, particularly for pregnant women who have undergone gastric bypass surgery in order to improve their fertility."

Commenting on the article, J AAPOS Editor-in-Chief David G. Hunter, MD, PhD, stated, "Weight-reduction surgery is becoming more common, especially with the potential for health benefits that result from reducing obesity. Unfort
'/>"/>

Contact: Lynelle Korte
l.korte@elsevier.com
314-447-9227
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2

Related biology news :

1. More than half the worlds population gets insufficient vitamin D, says UCR biochemist
2. Amid the murk of gut flora, vitamin D receptor emerges as a key player
3. Vitamin D and mental agility in elders
4. Model predicts individuals vitamin D needs
5. Model developed for manipulating vitamin D levels in calves
6. Researchers recommend pregnant women take 4,000 IU vitamin D a day
7. Low vitamin D levels are related to ms brain atrophy, cognitive function, studies show
8. Milk is Americas top source of much-needed vitamin D
9. Vitamin D status not predicted by surrogate markers, UB researchers find
10. Vitamin and calcium supplements may reduce breast cancer risk
11. BUSPH study links rheumatoid arthritis to vitamin D deficiency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... VIEW, Calif. , Nov. 20, 2014 ... higher driver efficiency are piloting the North American and ... number of accidents growing, gesture recognition systems that are ... make a mark in the industry. ... the Automotive Gesture Recognition Market in Europe ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)...   News Highlights: ... The Partners Data Lake, an agile data and ... will allow researcher and clinicians to explore and ... lives of patients , The Partners Data ... the Partners system, breaking down physical barriers for ...
Breaking Biology News(10 mins):Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... Chinese on EurekAlert! Chinese . An ... Vinatzer and Giorgio Balestra of the University of Tuscia in ... a devastating pathogen back to its likely origin. ... ) has been threatening the world,s kiwifruit industry and destroying ...
... natural habitat in farming areas that supports ladybugs could help ... help farmers reduce their costs, says a Michigan State University ... saving farmers an estimated $4.6 billion a year on insecticides. ... helping them to survive and thrive in areas where they ...
... announced today that it is a Grand Challenges Explorations winner, ... Dr. Gregor Reid and his team are the first ... The research project will study the impact of ... on the health outcomes of pregnant women and their children. ...
Cached Biology News:Virginia Tech and University of Tuscia lead team to unravel origin of devastating kiwifruit bacterium 2Virginia Tech and University of Tuscia lead team to unravel origin of devastating kiwifruit bacterium 3Increasing predator-friendly land can help farmers reduce costs 2Lawson recieves Grand Challenges Explorations grant for groundbreaking research 2
(Date:12/24/2014)... Dec. 23, 2014 Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that investors including Oracle ... Fund LLC and several Vermillion directors have agreed ... of Vermillion,s common stock and warrants to purchase ... private placement.  Under the terms ...
(Date:12/24/2014)... Sigma-Aldrich Corporation (NASDAQ: SIAL ... the Hart-Scott-Rodino Antitrust Improvements Act (HSR Act) in ... 2014, thereby completing the U.S. HSR Act antitrust ... the Company by Merck KGaA, Darmstadt, Germany.  ... to closing the transaction, which remains subject to ...
(Date:12/24/2014)... PARIS and NEW YORK ... data from its open-label pilot study of mazindol in ... Design, Development and Therapy in December 2014 . ... of mazindol in children with attention deficit/hyperactivity disorder" ( ... 2014 Dec 1;8:2321-2332. eCollection 2014 ) ...
(Date:12/22/2014)... ROCKVILLE, Md. , Dec. 22, 2014 ... MKT: SYN), a developer of pathogen-specific therapies ... focus on protecting the microbiome, today announced ... a Phase 1a clinical trial of SYN-004, ... the prevention of Clostridium difficile (C. ...
Breaking Biology Technology:Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5
... Outlines Ambitious Growth Plans, Technology Leadership, INDIANAPOLIS, ... AgroSciences, a wholly owned subsidiary of The Dow ... of a presentation made to investors,earlier today by ... was speaking at the Goldman Sachs Agricultural Chemicals,Conference ...
... February 12, Shire plc (LSE: SHP)(NASDAQ: SHPGY )(TSX: ... earnings on Thursday 21 February 2008., Results ... 12:00 GMT / 07:00 EST Investor meeting and ... Investor & Analyst meeting and conference call:, ...
... Healthcare Clients Throughout a ... Product,s Lifecycle, NEW ... Maryland-based MMG, an industry leader in patient,enrollment for clinical trials, will ... group. With this partnership, Ketchum,will greatly expand the depth of services ...
Cached Biology Technology:Dow AgroSciences' Success Presented to Wall Street 2Full Year 2007 Results Date Notification - 21 February 2008 2Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 2Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 3Ketchum Joins Forces with Clinical Trial Recruitment Agency MMG 4
One-step, microplate or cuvet, colorimetric, linear detection range 8 mg/dL to 300 mg/dL. Procedure: 5 min....
Homo sapiens jumping translocation breakpoint...
One-step, microplate or cuvet, colorimetric 530nm, detection limit 0.16mg/dL in serum or plasma. Procedure: 10 min....
MOUSE ANTI HUMAN NPM...
Biology Products: